Circadian variation of paroxysmal atrial fibrillation. PA3 Investigators. Atrial Pacing Peri-ablation for Prevention of Atrial Fibrillation Trial

Am J Cardiol. 2001 Mar 15;87(6):794-8, A8. doi: 10.1016/s0002-9149(00)01509-5.

Abstract

The circadian variation of paroxysmal atrial fibrillation (AF) was studied in 67 patients who received a dual-chamber pacemaker 3 months before a planned atrioventricular node ablation. A distinct circadian variation of AF was observed with 2 time peaks in initiation (1 in the early morning and 1 in the early evening hours), which was modulated by atrial pacing, the duration of AF, and the use of beta-adrenergic blocking agents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amiodarone / therapeutic use
  • Anti-Arrhythmia Agents
  • Atrial Fibrillation / physiopathology*
  • Atrial Fibrillation / therapy
  • Circadian Rhythm*
  • Cross-Over Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pacemaker, Artificial
  • Prospective Studies
  • Randomized Controlled Trials as Topic

Substances

  • Anti-Arrhythmia Agents
  • Amiodarone